Coronavirus Update: Novavax's $384m Is CEPI’s Biggest Vaccine Funding

Plus: Non-Coronavirus Trials Need To Re-Start, Says UK Sector

Man_In_Street_Mask
Back to work: lockdown measures are being lifted across Europe, but small steps are being taken to avoid new surges of cases.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip